Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-03-21
2006-03-21
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C424S649000
Reexamination Certificate
active
07015251
ABSTRACT:
This invention provides a method for increasing apoptosis in tumor cells and a method of decreasing a size of a tumor, said methods comprising contacting the tumor cells with: a) an effective amount of at least one antitumor chemotherapeutic agent and b) an effective amount of a ceramide, sequentially or concomitantly, wherein the apoptosis induced by the combination of the antitumor chemotherapeutic agent and the ceramide is greater than the apoptosis induced by contact of the tumor cells with either the antitumor chemotherapeutic agent alone or the ceramide alone. This invention also provides a method of treating cancer in a subject which comprises a method according to either of the above-described methods. This invention provides a method for treating cancer in a subject comprising administering to the subject an effective amount of at least one antitumor chemotherapeutic agent and an effective amount of at least one ceramide, sequentially or concomitantly. This invention provides a pharmaceutical composition comprising at least one antitumor chemotherapeutic agent in an amount effective to induce apoptosis of tumor cells and at least one ceramide in an amount effective to induce apoptosis of tumor cells and a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5478860 (1995-12-01), Wheeler
patent: 5597830 (1997-01-01), Klohs et al.
patent: 5631394 (1997-05-01), Wei et al.
patent: 6147060 (2000-11-01), Zasloff et al.
patent: 6841537 (2005-01-01), Joshi et al.
Carter et al., Chemotherapy of Cancer, second edition, 1981, John Wiley & Sons, N.Y.,N.Y. pp. 107-108.
Myrick, D., et al., “Taxol and ceramide act synergistically in the growth inhibition of Jurkat, a leukemic T-cell line”,FASEB Journal, vol. 11, No. 2, p. A546 (Abstract, 1997) (Exhibit 2).
Myrick, D.C., et al., “Paclitaxel-induced apoptosis in Jurkat, a leukemic T-cell, is enhanced by ceramide”,FASEB Journal, vol. 13, No. 4, Part 1, p. A191 (Abstract, Mar. 12, 1999) (Exhibit 3); and.
Myrick, Dorkina, et al., “Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramide”,Leukemia Research, vol. 23, No. 6, pp. 569-578 (Jun. 1999) (Exhibit 4).
Jayadev, S., et al., “Role for Ceramide in Cell Cycle Arrest”,J. Biol. Chem., 270(5):2047-2052 (1995).
Mycek, M., et al., “Lippincott's Illustrated Reviews: Pharmacology”, 2nded., Lippincott-Raven Pub., pp. 376, 390-392 (1997).
Mehta Shashikant
Wanebo Harold J.
Cooper & Dunham LLP
Roger Williams Hospital
White, Esq. John P.
LandOfFree
Combinations of ceramide and chemotherapeutic agents for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of ceramide and chemotherapeutic agents for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of ceramide and chemotherapeutic agents for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3587068